Celltrion Gets Positive CHMP Opinion for SteQeyma™ Autoinjector
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...
Tag : Celltrion
Celltrion’s Remdantry™ to launch in Canada on April 1, 2025
Celltrion, Inc., a leading global biopharmaceutical company, announced that Remdantry™ will be available in Canada as of April 1, 2025. Remdantry™, previously known as Inflectra®,...